LISATA THERAPEUTICS, INC. (LSTA) › Capital ExpendituresLISATA THERAPEUTICS, INC. (LSTA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $1.10M2011: $574.9K2012: $531.3K2013: $2.69M2014: $3.66M2015: $3.19M2016: $1.10M2017: $135.0K2018: $134.0K2019: $02020: $20.0K2021: $60.0K2022: $285.0K2023: $02024: $02025: $28.0K$28.0K2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$28.0K—2024$0—2023$0-100.0%2022$285.0K+375.0%2021$60.0K+200.0%2020$20.0K—2019$0-100.0%2018$134.0K-0.7%2017$135.0K-87.7%2016$1.10M-65.5%2015$3.19M-12.9%2014$3.66M+35.9%2013$2.69M+406.6%2012$531.3K-7.6%2011$574.9K-47.5%2010$1.10M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share